ODDB.org: Open Drug Database

Swissmedic Registration	62781	Date of registration	13.01.2014
Company name	Novartis Pharma Schweiz AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Tafinlar 50 mg	Hartkapseln	Capsules (Dabrafenibum 50 mg)	L01EC02	CI
02	Tafinlar 75 mg	Hartkapseln	Capsules (Dabrafenibum 75 mg)	L01EC02	CI

2025	©ywesee GmbH